0001209191-21-014542.txt : 20210225
0001209191-21-014542.hdr.sgml : 20210225
20210225205115
ACCESSION NUMBER: 0001209191-21-014542
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210223
FILED AS OF DATE: 20210225
DATE AS OF CHANGE: 20210225
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dagnon Terry
CENTRAL INDEX KEY: 0001760510
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37759
FILM NUMBER: 21683166
MAIL ADDRESS:
STREET 1: C/O ONCOBIOLOGICS, INC.
STREET 2: 7 CLARKE DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Outlook Therapeutics, Inc.
CENTRAL INDEX KEY: 0001649989
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 383982704
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 4260 U.S. ROUTE 1
CITY: MONMOUTH JUNCTION
STATE: NJ
ZIP: 08852
BUSINESS PHONE: 6096193990
MAIL ADDRESS:
STREET 1: 4260 U.S. ROUTE 1
CITY: MONMOUTH JUNCTION
STATE: NJ
ZIP: 08852
FORMER COMPANY:
FORMER CONFORMED NAME: Oncobiologics, Inc.
DATE OF NAME CHANGE: 20150804
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-23
0
0001649989
Outlook Therapeutics, Inc.
OTLK
0001760510
Dagnon Terry
C/O OUTLOOK THERAPEUTICS, INC.
4260 US ROUTE 1
MONMOUTH JUNCTION
NJ
08852
0
1
0
0
Chief Operating Officer
Common Stock
2021-02-23
4
S
0
15900
2.088
D
1127857
D
These shares were sold to cover taxes upon lapse of Issuer's repurchase right as to 25% of the shares as provided in that certain Consulting Agreement dated January 27, 2020.
/s/ Lawrence Kenyon, Attorney-in-Fact
2021-02-25